Terms: = Skin cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063
556 results:
1. GZ17-6.02 kills PDX isolates of uveal melanoma.
Booth L; Roberts JL; Spasojevic I; Baker KC; Poklepovic A; West C; Kirkwood JM; Dent P
Oncotarget; 2024 May; 15():328-344. PubMed ID: 38758815
[TBL] [Abstract] [Full Text] [Related]
2. Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/stat3 axis.
Neo SY; Tong L; Chong J; Liu Y; Jing X; Oliveira MMS; Chen Y; Chen Z; Lee K; Burduli N; Chen X; Gao J; Ma R; Lim JP; Huo J; Xu S; Alici E; Wickström SL; Haglund F; Hartman J; Wagner AK; Cao Y; Kiessling R; Lam KP; Westerberg LS; Lundqvist A
Sci Transl Med; 2024 May; 16(747):eadi2952. PubMed ID: 38748775
[TBL] [Abstract] [Full Text] [Related]
3. NRN1 interacts with Notch to increase oncogenic stat3 signaling in melanoma.
Devitt L; Westphal D; Pieger K; Schneider N; Bosserhoff AK; Kuphal S
Cell Commun Signal; 2024 May; 22(1):256. PubMed ID: 38705997
[TBL] [Abstract] [Full Text] [Related]
4. Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through stat3/Akt signaling pathway.
Yao N; Ma Q; Yi W; Zhu Y; Liu Y; Gao X; Zhang Q; Luo W
J Cancer Res Clin Oncol; 2024 Apr; 150(4):202. PubMed ID: 38630320
[TBL] [Abstract] [Full Text] [Related]
5. Inhibiting IL11RA to mitigate hepatic metastasis in skin cutaneous melanoma: Comprehensive insights from in vitro and in vivo investigations.
Zhang ZG; Zhu HM; Hua HK
Skin Res Technol; 2024 Mar; 30(3):e13618. PubMed ID: 38468436
[TBL] [Abstract] [Full Text] [Related]
6. Fucoxanthin induces human melanoma cytotoxicity by thwarting the JAK2/stat3/BCL-xL signaling axis.
Kuo MY; Dai WC; Chang JL; Chang JS; Lee TM; Chang CC
Environ Toxicol; 2024 Jun; 39(6):3356-3366. PubMed ID: 38444163
[TBL] [Abstract] [Full Text] [Related]
7. Effects of extracellular vesicles from adipose-derived stem cells on human keloid fibroblasts via the SOCS1/JAK2/stat3 pathway.
Ruan H; Wang J; Shi H; Luan W
J Cosmet Dermatol; 2024 Apr; 23(4):1404-1416. PubMed ID: 38288516
[TBL] [Abstract] [Full Text] [Related]
8. Uncovering the Anti-Angiogenic Mechanisms of
Zhao B; Li Y; Wang B; Liu J; Yang Y; Quan Q; An Q; Liang R; Liu C; Yang C
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257275
[TBL] [Abstract] [Full Text] [Related]
9. Radix Tetrastigma Hemsleyani Flavone represses cutaneous squamous cell carcinoma via Janus kinase/signal transducer and activator of transcription 3 pathway inactivation.
Peng J; Luo X; Wang T; Yue C; Duan M; Wu C
Cytokine; 2024 Mar; 175():156480. PubMed ID: 38232644
[TBL] [Abstract] [Full Text] [Related]
10. The predictive efficacy of programmed cell death in immunotherapy of melanoma: A comprehensive analysis of gene expression data for programmed cell death biomarker and therapeutic target discovery.
Yue C; Lian W; Duan M; Xia D; Cao X; Peng J
Environ Toxicol; 2024 Mar; 39(3):1858-1873. PubMed ID: 38140739
[TBL] [Abstract] [Full Text] [Related]
11. Targeting Fatty Acid Amide Hydrolase Counteracts the Epithelial-to-Mesenchymal Transition in Keratinocyte-Derived Tumors.
Kovacs D; Flori E; Bastonini E; Mosca S; Migliano E; Cota C; Zaccarini M; Briganti S; Cardinali G
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139209
[TBL] [Abstract] [Full Text] [Related]
12. Primary cutaneous CD30+ lymphoproliferative disorders with DUSP22 translocation.
Montes-Moreno S
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):136-139. PubMed ID: 38010388
[TBL] [Abstract] [Full Text] [Related]
13. Protopanaxatriol activates EGFR and HER2 to strengthen the molecules of skin protection in human keratinocytes.
You L; Shen T; Hu W; Cho JY
Phytomedicine; 2024 Jan; 123():155167. PubMed ID: 37952408
[TBL] [Abstract] [Full Text] [Related]
14. KIF22 promotes the proliferation and glycolysis of melanoma by activating EGFR/stat3 signaling.
Zhong Z; Zhong H
Clinics (Sao Paulo); 2023; 78():100307. PubMed ID: 37944197
[TBL] [Abstract] [Full Text] [Related]
15. Synthesis and characterization of piperic acid conjugates with homochiral and heterochiral dipeptides containing phenylalanine and their application in skin cancer.
Ur Rahim J; Faheem MM; Nawaz S; Goswami A; Rai R
Peptides; 2023 Dec; 170():171113. PubMed ID: 37923167
[TBL] [Abstract] [Full Text] [Related]
16. A systematic review regarding the prevalence of malignancy in patients with the hyper-IgE syndrome.
Mohammadi T; Azizi G; Rafiemanesh H; Farahani P; Nirouei M; Tavakol M
Clin Exp Med; 2023 Dec; 23(8):4835-4859. PubMed ID: 37924455
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
18. In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma Cell Lines and Benign Melanocytes.
Gambichler T; Harnischfeger F; Skrygan M; Majchrzak-Stiller B; Buchholz M; Müller T; Braumann C
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895015
[TBL] [Abstract] [Full Text] [Related]
19. What Is New in Cutaneous T Cell Lymphoma?
Morgenroth S; Roggo A; Pawlik L; Dummer R; Ramelyte E
Curr Oncol Rep; 2023 Nov; 25(11):1397-1408. PubMed ID: 37874473
[TBL] [Abstract] [Full Text] [Related]
20. Bufotalin Suppresses Proliferation and Metastasis of Triple-Negative Breast cancer Cells by Promoting Apoptosis and Inhibiting the stat3/EMT Axis.
Park SJ; Jung HJ
Molecules; 2023 Sep; 28(19):. PubMed ID: 37836626
[TBL] [Abstract] [Full Text] [Related]
[Next]
